Advocacy Archives | Page 4 of 17

Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.

by Laurie Adami

Putting the Patient in the Driver’s Seat

In her new book, Cancer Support Community executive chair Kim Thiboldeaux offers advice to patients on how to steer their way through a cancer diagnosis, treatment and beyond.

by Kevin McLaughlin

Making Connections at the AACR Annual Meeting 2021

Attending a scientific conference as a patient advocate can be an exhausting, overwhelming and hugely rewarding experience.

by Bradley Jones

Building COVID-19 Vaccine Confidence

Experts discussed how the cancer community can share accurate information and increase confidence in COVID-19 vaccines, both among people with cancer and the general population.

by Kevin McLaughlin

Chemobrain: It’s Not Your Imagination

Scientists discussed the mechanisms of chemotherapy-related cognitive impairment at a session dedicated to symptom science at the AACR Annual Meeting 2021.

by Marci A. Landsmann

Policy Matters

Research Advocacy During COVID-19

Continued federal funding to support biomedical research, including cancer research, is vitally important during the pandemic.

by Brandon Leonard, MA, and Marc Johnson, MPP

Q&A

Up for Debate

Hematologist-oncologist Vinayak K. Prasad describes his positions on cancer research and policy in a recently published book.

by Marci A. Landsmann

Survivor Profile

A Return to Carnival

With a renewed sense of purpose, stage IV lung cancer survivor Oswald Peterson returns to his parents' native Trinidad to celebrate the Caribbean festival.

by Lindsey Konkel

A Drive for Diversity

African Americans are underrepresented in the Be The Match bone marrow donor registry. Patient advocates are working to change that.

by Jon Kelvey

Patient Advocates Tune in for Precision Medicine Primer

Scientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers.

by Kevin McLaughlin